IFN-γ was significantly higher in active TB-LAP compared to IGRA-negative control and non-TB-LAP groups but did not show a significant difference compared to IGRA-positive controls, which can make it difficult to use in regions of high TB prevalence where the rate of latent TB infection is high. The gene discussed is IFNG; the disease is tuberculosis.